These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18957119)

  • 1. Use of an orthovoltage X-ray treatment unit as a radiation research system in a small-animal cancer model.
    Medina LA; Herrera-Penilla BI; Castro-Morales MA; García-López P; Jurado R; Pérez-Cárdenas E; Chanona-Vilchis J; Brandan ME
    J Exp Clin Cancer Res; 2008 Oct; 27(1):57. PubMed ID: 18957119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.
    Lotan Y; Stanfield J; Cho LC; Sherwood JB; Abdel-Aziz KF; Chang CH; Forster K; Kabbani W; Hsieh JT; Choy H; Timmerman R
    J Urol; 2006 May; 175(5):1932-6. PubMed ID: 16600801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
    Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
    Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
    Mach CM; Mathew L; Mosley SA; Kurzrock R; Smith JA
    Anticancer Res; 2009 Jun; 29(6):1895-9. PubMed ID: 19528445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemical internalization of bleomycin before external-beam radiotherapy improves locoregional control in a human sarcoma model.
    Norum OJ; Bruland ØS; Gorunova L; Berg K
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):878-85. PubMed ID: 19665318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical analysis of the antitumor efficacy of TS-1 using human uterine cervical cancer tumor xenografts.
    Nagai N; Komatsu M; Yunokawa M; Shiroyama Y; Hirata E
    Oncol Rep; 2008 Nov; 20(5):1149-56. PubMed ID: 18949415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
    Evans S; Dizeyi N; Abrahamsson PA; Persson J
    Anticancer Res; 2009 Oct; 29(10):3917-24. PubMed ID: 19846929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effects of hTR-siRNA adenovirus on human cervical cancer xenografts in nude mice].
    Li WY; Li MY; Xiao LY; Zhang CL; Liu YR; Li XY; Zhang SY; Li Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):711-4, 731. PubMed ID: 19024296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
    Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenovirus mediated angiostatin gene therapy for ovarian cancer: experiment with nude mice].
    Jia CR; Yang SY; Han SY; Sun L
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2204-8. PubMed ID: 19080673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
    Tan LT; Coles CE; Hart C; Tait E
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model.
    Kim HM; Lim J; Kang JS; Park SK; Lee K; Kim JY; Kim YJ; Hong JT; Kim Y; Han SB
    Int Immunopharmacol; 2009 Mar; 9(3):375-80. PubMed ID: 19105981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
    Ghous Z; Akhter J; Pourgholami MH; Morris DL
    Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.
    Mangoni M; Yue X; Morin C; Violot D; Frascogna V; Tao Y; Opolon P; Castaing M; Auperin A; Biti G; Barritault D; Vozenin-Brotons MC; Deutsch E; Bourhis J
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1242-50. PubMed ID: 19545790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
    Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
    Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.
    Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
    Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.